BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, Hirota T, Takeuchi K, Takahashi S, Yamaguchi K, Noda T. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Cancer Sci 2019;110:1352-63. [PMID: 30771244 DOI: 10.1111/cas.13967] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Nakamura Y, Kawazoe A, Lordick F, Janjigian YY, Shitara K. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm. Nat Rev Clin Oncol 2021;18:473-87. [PMID: 33790428 DOI: 10.1038/s41571-021-00492-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Onoyama T, Ishikawa S, Isomoto H. Gastric cancer and genomics: review of literature. J Gastroenterol 2022. [PMID: 35751736 DOI: 10.1007/s00535-022-01879-3] [Reference Citation Analysis]
3 Takahashi Y, Tsutsumi Y, Takeuchi C, Shiogama K, Mizutani Y, Inada KI, Yamamichi N, Koike K. Nuclear staining of claudin-18 is a new immunohistochemical marker for diagnosing intramucosal well-differentiated gastric adenocarcinoma. Pathol Int 2020;70:644-52. [PMID: 32623829 DOI: 10.1111/pin.12978] [Reference Citation Analysis]
4 Garcia-Pelaez J, Barbosa-Matos R, Gullo I, Carneiro F, Oliveira C. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges. Mol Oncol 2021. [PMID: 33724653 DOI: 10.1002/1878-0261.12948] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Businello G, Angerilli V, Lonardi S, Bergamo F, Valmasoni M, Farinati F, Savarino E, Spolverato G, Fassan M. Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter. Updates Surg 2022. [PMID: 35834132 DOI: 10.1007/s13304-022-01330-5] [Reference Citation Analysis]
6 Zhang L, Zhou A, Zhu S, Min L, Liu S, Li P, Zhang S. The role of GTPase-activating protein ARHGAP26 in human cancers. Mol Cell Biochem 2021. [PMID: 34716859 DOI: 10.1007/s11010-021-04274-3] [Reference Citation Analysis]
7 Körfer J, Lordick F, Hacker UT. Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View. Cancers (Basel) 2021;13:5216. [PMID: 34680363 DOI: 10.3390/cancers13205216] [Reference Citation Analysis]
8 Park JM, Han YM, Oh JY, Lee DY, Choi SH, Hahm KB. Transcriptome profiling implicated in beneficiary actions of kimchi extracts against Helicobacter pylori infection. J Clin Biochem Nutr 2021;69:171-87. [PMID: 34616109 DOI: 10.3164/jcbn.20-116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dhakras P, Uboha N, Horner V, Reinig E, Matkowskyj KA. Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma. Transl Gastroenterol Hepatol 2020;5:55. [PMID: 33073050 DOI: 10.21037/tgh.2020.01.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kim SR, Shin K, Park JM, Lee HH, Song KY, Lee SH, Kim B, Kim SY, Seo J, Kim JO, Roh SY, Kim IH. Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer. J Gastric Cancer 2020;20:408-20. [PMID: 33425442 DOI: 10.5230/jgc.2020.20.e33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hashimoto I, Oshima T. Claudins and Gastric Cancer: An Overview. Cancers (Basel) 2022;14:290. [PMID: 35053454 DOI: 10.3390/cancers14020290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
12 Alsina M, Diez M, Tabernero J. Emerging biological drugs for the treatment of gastroesophageal adenocarcinoma. Expert Opin Emerg Drugs 2021;26:385-400. [PMID: 34814781 DOI: 10.1080/14728214.2021.2010705] [Reference Citation Analysis]
13 Zhang WH, Zhang SY, Hou QQ, Qin Y, Chen XZ, Zhou ZG, Shu Y, Xu H, Hu JK. The Significance of the CLDN18-ARHGAP Fusion Gene in Gastric Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:1214. [PMID: 32983960 DOI: 10.3389/fonc.2020.01214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
15 Tong Y, Cheng PSW, Or CS, Yue SSK, Siu HC, Ho SL, Law SYK, Tsui WY, Chan D, Ma S, Lee SP, Chan ASY, Chan AS, Yun SW, Hui HS, Yuen ST, Leung SY, Yan HHN. Escape from cell-cell and cell-matrix adhesion dependence underscores disease progression in gastric cancer organoid models. Gut 2022:gutjnl-2022-327121. [PMID: 35705367 DOI: 10.1136/gutjnl-2022-327121] [Reference Citation Analysis]
16 Zhang Y, Sun J, Song Y, Gao P, Wang X, Chen M, Li Y, Wu Z. Roles of fusion genes in digestive system cancers: dawn for cancer precision therapy. Crit Rev Oncol Hematol 2022;:103622. [PMID: 35124200 DOI: 10.1016/j.critrevonc.2022.103622] [Reference Citation Analysis]
17 Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, Hirota T, Takeuchi K, Takahashi S, Yamaguchi K, Noda T. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Cancer Sci 2019;110:1352-63. [PMID: 30771244 DOI: 10.1111/cas.13967] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
18 Kyuno D, Takasawa A, Takasawa K, Ono Y, Aoyama T, Magara K, Nakamori Y, Takemasa I, Osanai M. Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. Tissue Barriers 2021;:1967080. [PMID: 34486479 DOI: 10.1080/21688370.2021.1967080] [Reference Citation Analysis]
19 Choi S, Park S, Kim H, Kang SY, Ahn S, Kim K. Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches. Biomedicines 2022;10:543. [DOI: 10.3390/biomedicines10030543] [Reference Citation Analysis]